Raymond James Financial
LEGN icon

Raymond James Financial’s Legend Biotech LEGN Stock Holding History

Raymond James Financial’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Buy
+8,171
New +$220K ﹤0.01% 4958
2025
Q4 		– Sell
-41,744
Closed -$1.36M – 5271
2025
Q3 		$1.36M Buy
41,744
+39,554
+1,806% +$1.46M ﹤0.01% 3475
2025
Q2 		$77.7K Buy
+2,190
New +$71K ﹤0.01% 4986

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Raymond James Financial's LEGN Position: Q2 2026 in Review

Raymond James Financial opened a new position in Legend Biotech (LEGN) in Q2 2026: 8,171 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #4958 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in LEGN as recently as Q3 2025.

Raymond James Financial first reported a position in LEGN in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.36M in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Raymond James Financial held 8,171 shares of Legend Biotech worth $236K as of Q2 2026.
  • Legend Biotech was a new Raymond James Financial position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4958 holding.
  • Raymond James Financial first reported a position in Legend Biotech in Q2 2025 and has held it in 3 quarters since.
  • Raymond James Financial's Legend Biotech position peaked at $1.36M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.